Hot Features
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation fo... MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -2.5641025641 | 1.17 | 1.295 | 1.135 | 1003236 | 1.21709215 | CS |
| 4 | 0.27 | 31.0344827586 | 0.87 | 1.295 | 0.784 | 1386265 | 1.07323876 | CS |
| 12 | 0.301 | 35.8760429082 | 0.839 | 1.295 | 0.6593 | 973257 | 0.91839539 | CS |
| 26 | -0.51 | -30.9090909091 | 1.65 | 1.65 | 0.6434 | 1092966 | 1.01596962 | CS |
| 52 | -1.25 | -52.3012552301 | 2.39 | 2.4 | 0.6434 | 936013 | 1.31034125 | CS |
| 156 | -3.2 | -73.732718894 | 4.34 | 5.545 | 0.6434 | 731638 | 2.75941683 | CS |
| 260 | -15.85 | -93.2901706886 | 16.99 | 17.44 | 0.6434 | 672727 | 4.31567746 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.